Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of ASP015K in adults with moderate to severe rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ASP015K

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED